Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Scotiabank Downgrades Edgewise Therapeutics to Sector Perform, Lowers Price Target to $14

Author: Benzinga Newsdesk | April 03, 2025 09:29am
Scotiabank analyst Louise Chen downgrades Edgewise Therapeutics (NASDAQ:EWTX) from Sector Outperform to Sector Perform and lowers the price target from $50 to $14.

Posted In: EWTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist